Urologic Oncology: Seminars and Original Investigations
Volume 25, Issue 3 , Pages 207-213, May 2007

Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: In vitro combined effects and a Phase II trial

  • Chia-Chi Lin, M.D., Ph.D.

      Affiliations

    • Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
    • Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan
  • ,
  • Chih-Hung Hsu, M.D., Ph.D.

      Affiliations

    • Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
    • Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan
  • ,
  • Tzyh-Chyuan Hour, Ph.D.

      Affiliations

    • Institute of Biochemistry, Kaohsiung Medical University, Kaohsiung, Taiwan
  • ,
  • Ann-Lii Cheng, M.D., Ph.D.

      Affiliations

    • Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
    • Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan
    • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
  • ,
  • Chao-Yuan Huang, M.D.

      Affiliations

    • Department of Urology, National Taiwan University Hospital, Taipei, Taiwan
  • ,
  • Kuo-How Huang, M.D.

      Affiliations

    • Department of Urology, National Taiwan University Hospital, Taipei, Taiwan
  • ,
  • Jun Chen, M.D.

      Affiliations

    • Department of Urology, National Taiwan University Hospital, Taipei, Taiwan
  • ,
  • Yeong-Shiau Pu, M.D., Ph.D.

      Affiliations

    • Department of Urology, National Taiwan University Hospital, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Tel.:+1-886-2-23123456 ext 5249; fax: +1-886-2-23219145.

Received 13 February 2006; received in revised form 31 May 2006; accepted 1 June 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(06)00149-9

doi:10.1016/j.urolonc.2006.06.002

Urologic Oncology: Seminars and Original Investigations
Volume 25, Issue 3 , Pages 207-213, May 2007